Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Appointed director
|
|
Eidos Therapeutics, Inc. (EIDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/28/2021 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Gifted 500 shares
@ $0
Unknown transaction of 380,467 shares
@ $0
Disposed/sold 70,000 options to buy
@ $13.2, valued at
$924k
|
|
| 01/28/2021 |
4
| Rohlen Douglas (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Disposed/sold 21,447 options to buy
@ $41.42, valued at
$888.3k
Disposed/sold 4,526 restricted stock units
@ $0 |
|
| 01/28/2021 |
4
| Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Disposed/sold 24,350 options to buy
@ $7.24, valued at
$176.3k
|
|
| 01/28/2021 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Unknown transaction of 50,699 shares
@ $0
Disposed/sold 9,469 options to buy
@ $17, valued at
$161k
Disposed/sold 53,157 options to buy
@ $13.2, valued at
$701.7k
|
|
| 01/28/2021 |
4
| Satvat Ali J. (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Disposed/sold 21,528 options to buy
@ $48.51, valued at
$1M
Disposed/sold 21,528 options to buy
@ $30.87, valued at
$664.6k
Disposed/sold 43,056 options to buy
@ $20.34, valued at
$875.8k
|
|
| 01/28/2021 |
4
| Lis William (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Disposed/sold 21,528 options to buy
@ $48.51, valued at
$1M
Disposed/sold 21,528 options to buy
@ $30.87, valued at
$664.6k
Disposed/sold 43,056 options to buy
@ $13.67, valued at
$588.6k
|
|
| 01/28/2021 |
4
| Hooper Suzanne Sawochka (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Disposed/sold 21,447 options to buy
@ $41.42, valued at
$888.3k
Disposed/sold 4,526 restricted stock units
@ $0 |
|
| 01/28/2021 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Gifted 3,000 shares
@ $0
Unknown transaction of 303,525 shares
@ $0
Disposed/sold 60,000 options to buy
@ $13.2, valued at
$792k
|
|
| 01/26/2021 |
4
| BridgeBio Pharma, Inc. (10% Owner) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Bought 14,428,836 shares
@ $0 |
|
| 01/15/2021 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 696 shares
@ $121.1094, valued at
$84.3k
Sold 572 shares
@ $122.2667, valued at
$69.9k
Sold 1,498 shares
@ $123.4787, valued at
$185k
Sold 4,934 shares
@ $124.7187, valued at
$615.4k
Sold 2,000 shares
@ $125.35, valued at
$250.7k
Sold 300 shares
@ $126.39, valued at
$37.9k
|
|
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 3,756 shares
@ $110.2906, valued at
$414.3k
Sold 7,600 shares
@ $111.3075, valued at
$845.9k
Sold 11,445 shares
@ $112.1903, valued at
$1.3M
Sold 3,493 shares
@ $112.9657, valued at
$394.6k
Exercised 4,451 options to buy
@ $17, valued at
$75.7k
Exercised 21,843 options to buy
@ $13.2, valued at
$288.3k
|
|
| 12/04/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 3,798 shares
@ $89.6267, valued at
$340.4k
Sold 702 shares
@ $90.6339, valued at
$63.6k
Sold 300 shares
@ $91.89, valued at
$27.6k
Sold 200 shares
@ $92.965, valued at
$18.6k
|
|
| 11/13/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 3,005 shares
@ $73.564, valued at
$221.1k
Sold 9,497 shares
@ $74.7457, valued at
$709.9k
Sold 908 shares
@ $75.2286, valued at
$68.3k
Gifted 1,500 shares
@ $0 |
|
| 11/10/2020 |
4
| Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 1,623 shares
@ $74.9287, valued at
$121.6k
Exercised 1,623 options to buy
@ $7.24, valued at
$11.8k
|
|
| 11/03/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 9,145 shares
@ $70.4438, valued at
$644.2k
Sold 3,146 shares
@ $71.4167, valued at
$224.7k
Sold 209 shares
@ $72.0961, valued at
$15.1k
Exercised 5,000 options to buy
@ $13.2, valued at
$66k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
|
|
| 10/30/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 1,300 shares
@ $71.9024, valued at
$93.5k
Sold 3,700 shares
@ $72.6016, valued at
$268.6k
|
|
| 10/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 69 shares
@ $52.08, valued at
$3.6k
Sold 100 shares
@ $52, valued at
$5.2k
Sold 4,831 shares
@ $52.3542, valued at
$252.9k
|
|
| 09/18/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 5,767 shares
@ $50.1576, valued at
$289.3k
|
|
| 09/16/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 111 shares
@ $50, valued at
$5.6k
Sold 1,000 shares
@ $50.064, valued at
$50.1k
Sold 3,122 shares
@ $50.1632, valued at
$156.6k
|
|
| 09/11/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 2,500 shares
@ $47, valued at
$117.5k
Exercised 2,500 options to buy
@ $17, valued at
$42.5k
|
|
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $50, valued at
$250k
|
|
| 07/01/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Acquired 1,088 shares
@ $0 |
|
| 06/05/2020 |
4
| Turtle Cameron (Chief Business Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 376 shares
@ $41.5735, valued at
$15.6k
|
|
| 06/05/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 444 shares
@ $41.5735, valued at
$18.5k
Gifted 1,020 shares
@ $0
Gifted 1,020 shares
@ $0
Sold 5,000 shares
@ $50, valued at
$250k
|
|
| 06/05/2020 |
4
| Valle Franco (Senior Vice President, Finance) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 444 shares
@ $41.5735, valued at
$18.5k
|
|
| 06/05/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 444 shares
@ $41.5735, valued at
$18.5k
|
|
| 06/01/2020 |
4
| Fox Jonathan C (See Remarks) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $50, valued at
$250k
|
|
| 05/29/2020 |
4
| AGUIAR ERIC (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 21,528 options to buy
@ $48.51, valued at
$1M
|
|
| 05/29/2020 |
4
| Shah Rajeev M. (Director) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 21,528 options to buy
@ $48.51, valued at
$1M
|
|
|
|
|